Pediatric COVID-19 Vaccine Clinical Studies
Part of the continued fight against COVID-19 is to develop vaccines to prevent the disease in young children. Although most children with COVID may only have mild to no symptoms at all, some children can get severely ill. Children can also spread the virus.
Parents, please consider allowing your child(ren) to participate in a COVID vaccine research study. We need your help.
To be eligible your child must be:
- Female or male 6 months – < 12 years of age
- Relatively healthy and not previously diagnosed with COVID or had a COVID vaccine
- Willing to have injections and blood draws
All participants will have the opportunity to receive COVID-19 study vaccine during their time in the study. Interested in learning more? There’s no obligation. For more information, fill out the form below or please call 615-329-2222 for more details.
Our team is helping to evaluate the safety and immune response generated by an investigational bivalent (combined) COVID-19 vaccine as a primary 3-dose series plus booster in healthy children 6 months to less than 5 years of age.
The vaccine being studied is a combination of the original Pfizer & BioNTech vaccine (BNT162b2 Original) and an investigational vaccine for Omicron subtypes BA.4 and BA.5 (BNT162b2 Omicron BA.4/BA.5).
Please fill out our no-obligation form below to speak with one of our patient engagement team members and learn more about the study, or call us at (615) 329-2222.